Verisante Technology Inc (VRS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Verisante Technology Inc (VRS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011945
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a multispectral imaging camera used in the detection of oral and skin cancer. The cancer detection technology helps the company to develop and offer wide range of compact and non-invasive cancer detection devices. The company is ISO 13485:2003 certified as a medical device manufacturer. Verisante is headquartered in Richmond, British Columbia, Canada.

Verisante Technology Inc (VRS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verisante Technology Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Verisante Technology Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Verisante Technology Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Verisante Technology Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Verisante Technology Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Verisante Technology Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Verisante Technology Acquires ClearVu Rights From Perceptronix Medical 10
Partnerships 12
Verisante Enters Into Licensing Agreement With British Columbia Cancer Agency 12
Verisante Plans to Form Joint Venture with Astoria Capital 13
Verisante Technology Enters Into Agreement With BC Cancer Agency And Fujian Normal University 14
Verisante to Enter into Licensing Agreement to Develop Core Device for Lung Cancer 15
Equity Offering 16
Verisante Technology Raises USD0.08 Million in Private Placement of Shares 16
Verisante Technology Raises USD0.3 Million in Private Placement of Shares 17
Verisante Raises USD0.27 Million in Private Placement of Shares 18
Verisante Raises USD0.27 Million in Private Placement of Shares 19
Verisante Technology Completes Private Placement Of Units For US$0.4 Million 20
Verisante Technology Completes Private Placement Of Units For US$1 Million 21
Verisante Technology Completes Private Placement Of Units For US$0.92 Million 22
Verisante Technology Announces Private Placement Of Units In US For Up To US$5 Million 23
Verisante Technology Completes Private Placement Of US$5.05 Million 24
Verisante Technology Completes Private Placement Of US$0.99 Million 25
Verisante Technology Inc – Key Competitors 26
Verisante Technology Inc – Key Employees 27
Verisante Technology Inc – Locations And Subsidiaries 28
Head Office 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Verisante Technology Inc, Medical Equipment, Key Facts, 2016 2
Verisante Technology Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Verisante Technology Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Verisante Technology Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Verisante Technology Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Verisante Technology Inc, Deals By Market, 2011 to YTD 2017 8
Verisante Technology Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Verisante Technology Acquires ClearVu Rights From Perceptronix Medical 10
Verisante Enters Into Licensing Agreement With British Columbia Cancer Agency 12
Verisante Plans to Form Joint Venture with Astoria Capital 13
Verisante Technology Enters Into Agreement With BC Cancer Agency And Fujian Normal University 14
Verisante to Enter into Licensing Agreement to Develop Core Device for Lung Cancer 15
Verisante Technology Raises USD0.08 Million in Private Placement of Shares 16
Verisante Technology Raises USD0.3 Million in Private Placement of Shares 17
Verisante Raises USD0.27 Million in Private Placement of Shares 18
Verisante Raises USD0.27 Million in Private Placement of Shares 19
Verisante Technology Completes Private Placement Of Units For US$0.4 Million 20
Verisante Technology Completes Private Placement Of Units For US$1 Million 21
Verisante Technology Completes Private Placement Of Units For US$0.92 Million 22
Verisante Technology Announces Private Placement Of Units In US For Up To US$5 Million 23
Verisante Technology Completes Private Placement Of US$5.05 Million 24
Verisante Technology Completes Private Placement Of US$0.99 Million 25
Verisante Technology Inc, Key Competitors 26
Verisante Technology Inc, Key Employees 27

★海外企業調査レポート[Verisante Technology Inc (VRS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hino Motors Ltd (7205):企業の財務・戦略的SWOT分析
    Hino Motors Ltd (7205) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Wm Morrison Supermarkets PLC:企業の戦略・SWOT・財務情報
    Wm Morrison Supermarkets PLC - Strategy, SWOT and Corporate Finance Report Summary Wm Morrison Supermarkets PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Rexahn Pharmaceuticals Inc (RNN):企業の財務・戦略的SWOT分析
    Summary Rexahn Pharmaceuticals Inc (Rexahn Pharmaceuticals), formerly Corporate Road Show.com Inc is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer. The company develops anti-cancer drug candidates including Archexin that is intended for the tre …
  • ShawCor Ltd (SCL):企業の財務・戦略的SWOT分析
    ShawCor Ltd (SCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Creganna Medical:企業の戦略的SWOT分析
    Creganna Medical - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Global Investment House KPSC:企業の戦略的SWOT分析
    Global Investment House KPSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • The E. W. Scripps Company:企業の戦略・SWOT・財務情報
    The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report Summary The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Steel Connect Inc (STCN):企業の財務・戦略的SWOT分析
    Steel Connect Inc (STCN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • THIMM Group GmbH + Co. KG:企業の戦略・SWOT・財務情報
    THIMM Group GmbH + Co. KG - Strategy, SWOT and Corporate Finance Report Summary THIMM Group GmbH + Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Fortress Biotech Inc (FBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Fortress Biotech Inc (Fortress), formerly Coronado Biosciences Inc is a biopharmaceutical company that develops and commercializes pharmaceutical and biotechnology products. The company offers products in the areas of dermatology, cancer, pain management and autoimmune diseases, among others …
  • Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • Chariot Oil & Gas Ltd (CHAR):企業の財務・戦略的SWOT分析
    Summary Chariot Oil & Gas Ltd (CHAR) is an oil and gas exploration company that create transformational stakeholder value through the discovery of material accumulations of hydrocarbons. The company provides services such as drilling and extracting services for oil and gas resources. It also offers …
  • Mizuho Financial Group Inc:企業の戦略・SWOT・財務分析
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Puma Biotechnology Inc (PBYI):製薬・医療:M&Aディール及び事業提携情報
    Summary Puma Biotechnology Inc (Puma) is a biopharmaceutical company that develops novel therapeutics for the treatment of cancer. The company develops and commercializes three drug candidates, namely, PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Its pipeline portfolio also enc …
  • Hansen Medical Inc:企業の製品パイプライン分析2018
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Health Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products comprise robotic system, robotic catheters, s …
  • Aerovironment Inc
    Aerovironment Inc - Strategy, SWOT and Corporate Finance Report Summary Aerovironment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Connect Catering Limited:企業の戦略・SWOT・財務情報
    Connect Catering Limited - Strategy, SWOT and Corporate Finance Report Summary Connect Catering Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析
    Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • ICICI Bank Ltd:企業の戦略・SWOT・財務情報
    ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • SACI Falabella:企業の戦略・SWOT・財務情報
    SACI Falabella - Strategy, SWOT and Corporate Finance Report Summary SACI Falabella - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆